Foundation Medicine, Inc. FMI
Set alert
At close · Jun 28
- Open
- 137.00
- Prev close
- 137.00
- Mkt cap
- 0
- Vol
- 0
- Avg vol
- 347.22K
- EPS
- -3.87
- P/E
- -35.39
- Div yield
- 0.00%
More statistics
- Low
- 137.00
- High
- 137.00
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2018
- 50-d avg
- 0.00
- 200-d avg
- 0.00
News
2 weeks ago gurufocus.com
Is Fastenal Co (FAST) Overvalued After Q3 Earnings Beat? EPS at $0.35 vs Estimated $0.34, Revenue at $2.463 Billion vs Estimated $2.440 Billion -- GF Score: 95/100
Fastenal Co (FAST) released its 8-K filing on October 14, 2026, revealing robust performance figures for the third quarter ended September 30, 2026. The company
6 months ago gurufocus.com
Fastenal Co (FAST) Q1 2026 Earnings Call Highlights: Strong Sales Growth Amid Pricing Challenges
Daily Sales Growth: 12.4% increase to $34.9 million per day.Operating Margin: Improved to 20.3%, up 20 basis points from last year.Digital Sales: Digital chann
1 year ago prnewswire.com
Spirit Announces Sale of Fiber Materials Inc. (FMI) to Tex Tech Industries
WICHITA, Kan. , Jan. 13, 2025 /PRNewswire/ -- Today, Spirit AeroSystems Holdings, Inc. (NYSE: SPR) ("Spirit," "Spirit AeroSystems" or the "Company") announced the sale of Fiber Materials Inc ("FMI")…
1 year ago prnewswire.com
Spirit Announces Purchase Agreement with Tex Tech Industries for Intended Sale of Fiber Materials, Inc. (FMI)
WICHITA, Kan. , Nov. 18, 2024 /PRNewswire/ -- Today, Spirit AeroSystems Holdings, Inc. (NYSE: SPR) ("Spirit," "Spirit AeroSystems" or the "Company") announces a purchase agreement to sell Fiber…
2 years ago globenewswire.com
Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator
BOSTON and PRINCETON, N.J., May 29, 2024 (GLOBE NEWSWIRE) -- Foundation Medicine, Inc. and PMV Pharmaceuticals, Inc. (NASDAQ: PMVP; “PMV Pharma”) today announced a partnership to develop Foundation…
8 years ago businesswire.com
Foundation Medicine Announces Timing for First Quarter 2018 Financial Results and Conference Call
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's first quarter ended March 31, 2018 will be released on Wednesday,…
8 years ago businesswire.com
Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2017 Financial Results and Conference Call
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's fourth quarter and year ended December 31, 2017 will be released on…
8 years ago businesswire.com
FDA Approves Foundation Medicine’s FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that the U.S. Food and Drug Administration (FDA) approved FoundationOne CDx™, the company’s comprehensive…
9 years ago businesswire.com
Foundation Medicine Announces Timing for Third Quarter 2017 Financial Results and Conference Call
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's third quarter ended September 30, 2017 will be released on…
9 years ago businesswire.com
Foundation Medicine Announces Timing for Second Quarter 2017 Financial Results and Conference Call
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's second quarter ended June 30, 2017 will be released on Tuesday,…
9 years ago businesswire.com
Foundation Medicine Announces Timing for First Quarter 2017 Financial Results and Conference Call
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's first quarter ended March 31, 2017 will be released on Tuesday, May…
9 years ago businesswire.com
Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2016 Financial Results and Conference Call
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's fourth quarter and year ended December 31, 2016 will be released on…
9 years ago businesswire.com
Foundation Medicine Reports Preliminary 2016 Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine (NASDAQ:FMI) today announced preliminary unaudited total revenue of approximately $28.8 million in the fourth quarter of 2016 and approximately…
10 years ago businesswire.com
Foundation Medicine Announces Timing for Third Quarter 2016 Financial Results and Conference Call
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's third quarter ended September 30, 2016, will be released on…
10 years ago businesswire.com
Foundation Medicine Announces Timing for Second Quarter 2016 Financial Results and Conference Call
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's second quarter ended June 30, 2016, will be released on Tuesday,…
10 years ago businesswire.com
Foundation Medicine Announces Timing for First Quarter 2016 Financial Results and Conference Call
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's first quarter ended March 31, 2016, will be released on Tuesday, May…
10 years ago businesswire.com
Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2015 Financial Results and Conference Call
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's fourth quarter and year ended December 31, 2015, will be released on…
10 years ago businesswire.com
Foundation Medicine Reports Preliminary 2015 Results and Provides 2016 Business Outlook, including Commercial Launch of its ctDNA Assay
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine (NASDAQ:FMI) today announced preliminary unaudited total revenue of approximately $26.1 million in the fourth quarter of 2015 and $93.2 million…
11 years ago businesswire.com
Foundation Medicine Announces Timing for Third Quarter 2015 Financial Results and Conference Call
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's third quarter ended September 30, 2015, will be released on Tuesday,…
11 years ago businesswire.com
Foundation Medicine Announces Timing for Second Quarter 2015 Financial Results and Conference Call
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) today announced that financial results for the company's second quarter ended June 30, 2015, will be released on Wednesday,…